Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Minerva Biotechnologies Corp.

Headquarters: Waltham, MA, United States of America
Year Founded: 1999
Status: Private

BioCentury | Feb 1, 2024
Data Byte

World’s first TIL therapy among FDA’s five February PDUFA dates

An approval for Iovance’s lifileucel would mark the entry of immune cell therapies into solid tumors
BioCentury | Oct 27, 2023
Management Tracks

CFO John Kuch to retire from Xencor

Plus: Verastem hires new commercial and regulatory heads, and new CTO at Actym
BioCentury | Sep 7, 2015
Company News

Minerva Biotechnologies, Kyoto University deal

BioCentury | Dec 7, 2009
Company News

Clarient, Minerva Biotechnologies deal

BioCentury | May 18, 2009
Clinical News

Minerva Biotechnologies preclinical data

BioCentury | May 12, 2008
Clinical News

Minerva Biotechnologies preclinical data

Items per page:
1 - 8 of 8